Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
No Association Between High-Sensitivity C-Reactive Protein and Carotid Intima-Media Progression: The APAC Study
First author：Anxin Wang,Xiaoya Huang
Corresponding author：Xiuhua Guo,Shouling Wu,Xingquan Zhao
essential_information
- Person in charge：Anxin Wang,Xiaoya Huang
- Data Sources： APAC
- Number of papers：APAC20180043
- Published time：2017-02-15
2017-02-15
Published articles
Journal：Journal of Stroke and Cerebrovascular Diseases
Publication type: Original Contributions
IF(IF): 1.5174
PMID: 27742537 Link To Pubmed Full text Download
Background And Purpose
High-sensitivity C-reactive protein (hs-CRP) is a risk indicator for atherosclerosis. However, the association between hs-CRP and early carotid atherosclerosis progression is not well established. We undertook a prospective, community-based, observational study to address this question.
Method
Common carotid artery intima-media thickness (IMT) and hs-CRP values were measured at baseline and after 2 years of follow-up in subjects ≥40 years of age who were participating in the Asymptomatic Polyvascular Abnormalities Community study. Association between hs-CRP values and IMT progression was determined before and after controlling for vascular risk factors.
Conclusion
Our results suggest that hs-CRP is not a predictor for the progression of early atherosclerotic changes of the carotid arteries. The hs-CRP levels in early atherosclerosis might be considered as risk markers rather than having a causal role.
Main results
IMT was measured in a total of 1918 subjects at baseline and 52.97% of those (1016 of 1918) had IMT progression after 2 years. No significant association between progression of IMT over a 2-year period and average hs-CRP levels was found (multivariateadjusted, P for trend = .280). Both hs-CRP values measured at baseline (P = .836) and after 2 years of follow-up (P = .440) were not associated with IMT progression levels. Average hs-CRP values were not related to IMT progression levels in a dose-response manner (P = .784). In a subgroup analysis stratified by age and sex, hs-CRP values were also not significantly associated with IMT progression levels (P > .05).